Blog / Archives
J.P. Morgan Healthcare Conference This Week: ARIA
We will publish updates this week from the Conference. As of 3:45p EST the biotech sector is rallying. The IBB is up 1.6% and the XBI is up 3.5%. Biotech stocks were helped by the buyout of Ariad...
Wet and Wild AR Storms Hit the West Coast: LaNina Madness
AR Storms Deliver Record Precipitation-The "Pineapple Express" By now you know it seems like the coldest wettest and coldest winter on the West Coast and the next week will bring even bigger...
Biotech Blahs: Out of Favor But Great For Stock Pickers…Update-2
Update-2...1/6/17-- Three Day Biotech Rally...12N EST NASDAQ at New Highs 5532 XBI is up 5 points since last Friday's close to $63.45;The IBB is up 16 points to $280. Investors are betting on a...
Life Science Sector Review: Diagnostics and Tools Update
Life Science Sector: What's Going On With Dx and Tools Stocks? We dropped coverage of Life Science diagnostics and tools stocks in January 2016 just after the severe market correction began. Of...
Biotechs Fade Again In Late Day Sell-Off
Biotechs Fade After Promising Start-Smaller Cap Winners Biotech stocks got a jump-start this morning peaked quickly then abruptly sold off at about 2p. The IBB ended down 1.33% to 268.79 off recent...
Biotechs Mixed Hurt by Alexion (ALXN) and Ophthotech (OPHT)…Update-1
Update-1 2:30P EST... Improved Tone in Selective Biotech Stocks Maybe it's bottom fishing or the end of tax selling but today we can see buyers coming in for large cap biotechs. However the backdrop...
Biotechs Unhinged by Tough Pricing Talk
Biotechs Unhinged-Roiled by Commentary and Tweet storms Biotech stocks rallied briefly early in the week but sold off abruptly over the past two days with a quote from Trump in a Time Person of the...
Market Reversal in Biotech But Healthcare Stocks Are Still Muddled
Market Reversal in Biotech Offers Bullish Set-Up After one of the worst down days in months yesterday biotech stocks broadly reversed today giving a short term "nibble" signal. The macro environment...
Alert: Alzheimer’s Drug Fails in Clinical Trial-Stocks Sink: ACIU,BIIB,LLY…Update-1
Another clinical trial failure for an Alzheimer's Disease in a late stage trial triggered a pre-market sell-off. Both Biogen (BIIB) -aducanumab- and Lilly (LLY)- solanezumab -drugs in development...
Rayno Biobeat #4: Sector Shift Underway but what’s next for biotech?…Update-1
Update-1 November 28 Another nasty day for biotech A bit of a selloff in the market indices today with the NASDAQ down 0.58% and the S&P down 0.53%. The highly touted Russell 2000 (IWM) was down...